Cargando…
Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison
Previous studies have shown that the co-existence of bone marrow failure and pulmonary fibrosis in a single patient or in a family is suggestive of telomere related genes (TRG) germline mutations. This study presents the genetic background, clinical characteristics, and outcome of a group of five Gr...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693222/ https://www.ncbi.nlm.nih.gov/pubmed/31409344 http://dx.doi.org/10.1186/s12931-019-1151-6 |
_version_ | 1783443669862318080 |
---|---|
author | Papiris, Spyros A. Tsirigotis, Panagiotis Kannengiesser, Caroline Kolilekas, Lykourgos Gkirkas, Konstantinos Papaioannou, Andriana I. Revy, Patrick Giouleka, Paschalina Papadaki, Georgia Kagouridis, Konstantinos Pappa, Vassiliki Borie, Raphael Boileau, Catherine Bouros, Demosthenes Crestani, Bruno Manali, Effrosyni D. |
author_facet | Papiris, Spyros A. Tsirigotis, Panagiotis Kannengiesser, Caroline Kolilekas, Lykourgos Gkirkas, Konstantinos Papaioannou, Andriana I. Revy, Patrick Giouleka, Paschalina Papadaki, Georgia Kagouridis, Konstantinos Pappa, Vassiliki Borie, Raphael Boileau, Catherine Bouros, Demosthenes Crestani, Bruno Manali, Effrosyni D. |
author_sort | Papiris, Spyros A. |
collection | PubMed |
description | Previous studies have shown that the co-existence of bone marrow failure and pulmonary fibrosis in a single patient or in a family is suggestive of telomere related genes (TRG) germline mutations. This study presents the genetic background, clinical characteristics, and outcome of a group of five Greek patients co-affected with IPF and MDS. Four out of five patients developed an IPF acute exacerbation that was not reversible. We failed to detect any mutation in the TERT, TERC, DKC1, TINF2, RTEL1, PARN, NAF1, ACD, NHP2 and NOP10 genes in any patient. Moreover, telomere length was normal in the two patients tested. This could suggest that although the co-occurence of IPF and MDS are suggestive of TRG mutation in patients < 65 years old, in the elderly it may occur without germline mutations and could negatively affect prognosis. Physicians should be aware for possible IPF deterioration and therapeutic options for MDS should be wisely considered. |
format | Online Article Text |
id | pubmed-6693222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66932222019-08-16 Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison Papiris, Spyros A. Tsirigotis, Panagiotis Kannengiesser, Caroline Kolilekas, Lykourgos Gkirkas, Konstantinos Papaioannou, Andriana I. Revy, Patrick Giouleka, Paschalina Papadaki, Georgia Kagouridis, Konstantinos Pappa, Vassiliki Borie, Raphael Boileau, Catherine Bouros, Demosthenes Crestani, Bruno Manali, Effrosyni D. Respir Res Letter to the Editor Previous studies have shown that the co-existence of bone marrow failure and pulmonary fibrosis in a single patient or in a family is suggestive of telomere related genes (TRG) germline mutations. This study presents the genetic background, clinical characteristics, and outcome of a group of five Greek patients co-affected with IPF and MDS. Four out of five patients developed an IPF acute exacerbation that was not reversible. We failed to detect any mutation in the TERT, TERC, DKC1, TINF2, RTEL1, PARN, NAF1, ACD, NHP2 and NOP10 genes in any patient. Moreover, telomere length was normal in the two patients tested. This could suggest that although the co-occurence of IPF and MDS are suggestive of TRG mutation in patients < 65 years old, in the elderly it may occur without germline mutations and could negatively affect prognosis. Physicians should be aware for possible IPF deterioration and therapeutic options for MDS should be wisely considered. BioMed Central 2019-08-13 2019 /pmc/articles/PMC6693222/ /pubmed/31409344 http://dx.doi.org/10.1186/s12931-019-1151-6 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Letter to the Editor Papiris, Spyros A. Tsirigotis, Panagiotis Kannengiesser, Caroline Kolilekas, Lykourgos Gkirkas, Konstantinos Papaioannou, Andriana I. Revy, Patrick Giouleka, Paschalina Papadaki, Georgia Kagouridis, Konstantinos Pappa, Vassiliki Borie, Raphael Boileau, Catherine Bouros, Demosthenes Crestani, Bruno Manali, Effrosyni D. Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison |
title | Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison |
title_full | Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison |
title_fullStr | Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison |
title_full_unstemmed | Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison |
title_short | Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison |
title_sort | myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693222/ https://www.ncbi.nlm.nih.gov/pubmed/31409344 http://dx.doi.org/10.1186/s12931-019-1151-6 |
work_keys_str_mv | AT papirisspyrosa myelodysplasticsyndromesandidiopathicpulmonaryfibrosisadangerousliaison AT tsirigotispanagiotis myelodysplasticsyndromesandidiopathicpulmonaryfibrosisadangerousliaison AT kannengiessercaroline myelodysplasticsyndromesandidiopathicpulmonaryfibrosisadangerousliaison AT kolilekaslykourgos myelodysplasticsyndromesandidiopathicpulmonaryfibrosisadangerousliaison AT gkirkaskonstantinos myelodysplasticsyndromesandidiopathicpulmonaryfibrosisadangerousliaison AT papaioannouandrianai myelodysplasticsyndromesandidiopathicpulmonaryfibrosisadangerousliaison AT revypatrick myelodysplasticsyndromesandidiopathicpulmonaryfibrosisadangerousliaison AT gioulekapaschalina myelodysplasticsyndromesandidiopathicpulmonaryfibrosisadangerousliaison AT papadakigeorgia myelodysplasticsyndromesandidiopathicpulmonaryfibrosisadangerousliaison AT kagouridiskonstantinos myelodysplasticsyndromesandidiopathicpulmonaryfibrosisadangerousliaison AT pappavassiliki myelodysplasticsyndromesandidiopathicpulmonaryfibrosisadangerousliaison AT borieraphael myelodysplasticsyndromesandidiopathicpulmonaryfibrosisadangerousliaison AT boileaucatherine myelodysplasticsyndromesandidiopathicpulmonaryfibrosisadangerousliaison AT bourosdemosthenes myelodysplasticsyndromesandidiopathicpulmonaryfibrosisadangerousliaison AT crestanibruno myelodysplasticsyndromesandidiopathicpulmonaryfibrosisadangerousliaison AT manalieffrosynid myelodysplasticsyndromesandidiopathicpulmonaryfibrosisadangerousliaison |